Skip to main content

Advertisement

Log in

Global research trends in radiotherapy for breast cancer: a systematic bibliometric analysis

  • Original Article
  • Published:
Japanese Journal of Radiology Aims and scope Submit manuscript

Abstract

Purpose

Breast cancer is the most common malignant tumor in women. Radiotherapy (RT) is an important adjunctive therapy for breast cancer, but the current international research trend of RT in breast cancer treatment and management is unclear. This bibliometric analysis was conducted to investigate the current trends and hot topics in this area.

Materials and methods

The Web of Science Core Collection (WoSCC; Clarivate) database was searched, VOSviewer 1.6.18 and CiteSpace 6.1.R2 software were employed for the quantitative and qualitative analysis.

Results

12,268 publications were included in this bibliometric analysis. There was an increasing trend of publications and international collaborations in the topic. The United States and The University of Texas MD Anderson Cancer Center were the most productive countries and institutions, respectively. The analysis of journals showed researches focused on both basic and clinical medicine on breast cancer RT. Park Won published the most papers and Fisher B had the most co-citations. The most co-cited paper was published in the Lancet. Survival, risk, chemotherapy, mastectomy, and surgery were regarded as current research hotspots through the analysis of keywords.

Conclusion

Through quantitative and qualitative bibliometric analyses, this study provides insights into the research trends and potential research hotspots on breast cancer RT.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

References

  1. Thompson JL, Wright GP. The role of breast MRI in newly diagnosed breast cancer: an evidence-based review. Am J Surg. 2021;221:525–8.

    Article  PubMed  Google Scholar 

  2. Yersal O, Barutca S. Biological subtypes of breast cancer: prognostic and therapeutic implications. World J Clin Oncol. 2014;5:412–24.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Weigelt B, Mackay A, A’Hern R, Natrajan R, Tan DS, Dowsett M, et al. Breast cancer molecular profiling with single sample predictors: a retrospective analysis. Lancet Oncol. 2010;11:339–49.

    Article  CAS  PubMed  Google Scholar 

  4. Zhang YN, Xia KR, Li CY, Wei BL, Zhang B. Review of breast cancer pathologigcal image processing. Biomed Res Int. 2021;2021:1994764.

    PubMed  PubMed Central  Google Scholar 

  5. Ashwanikumar N, Plaut JS, Mostofian B, Patel S, Kwak P, Sun C, et al. Supramolecular self assembly of nanodrill-like structures for intracellular delivery. J Control Release. 2018;282:76–89.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. McDonald ES, Clark AS, Tchou J, Zhang P, Freedman GM. Clinical diagnosis and management of breast cancer. J Nucl Med. 2016;57(Suppl 1):9S-16S.

    Article  PubMed  Google Scholar 

  7. Paik S, Shak S, Tang G, Kim C, Baker J, Cronin M, et al. A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. N Engl J Med. 2004;351:2817–26.

    Article  CAS  PubMed  Google Scholar 

  8. Gradishar WJ, Anderson BO, Blair SL, Burstein HJ, Cyr A, Elias AD, et al. Breast cancer version 3.2014. J Natl Compr Canc Netw. 2014;12:542–90.

    Article  CAS  PubMed  Google Scholar 

  9. Correa C, McGale P, Taylor C, Wang Y, Clarke M, Davies C, et al. Overview of the randomized trials of radiotherapy in ductal carcinoma in situ of the breast. J Natl Cancer Inst Monogr. 2010;2010:162–77.

    Article  CAS  PubMed  Google Scholar 

  10. Darby S, McGale P, Correa C, Taylor C, Arriagada R, Clarke M, et al. Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials. Lancet. 2011;378:1707–16.

    Article  CAS  PubMed  Google Scholar 

  11. McCormick B, Winter K, Hudis C, Kuerer HM, Rakovitch E, Smith BL, et al. RTOG 9804: a prospective randomized trial for good-risk ductal carcinoma in situ comparing radiotherapy with observation. J Clin Oncol. 2015;33:709–15.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Green MD, Brenneman R, Powell SN, Bergom C. Harnessing the DNA repair pathway in breast cancer: germline mutations/polymorphisms in breast radiation. Semin Radiat Oncol. 2022;32:298–302.

    Article  PubMed  Google Scholar 

  13. Cooper ID. Bibliometrics basics. J Med Libr Assoc. 2015;103:217–8.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Verma S, Gustafsson A. Investigating the emerging COVID-19 research trends in the field of business and management: a bibliometric analysis approach. J Bus Res. 2020;118:253–61.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Donthu N, Kumar S, Pandey N. A retrospective evaluation of marketing intelligence and planning: 1983–2019. Mark Intell Plan. 2021;39:48–73.

    Article  Google Scholar 

  16. Donthu N, Kumar S, Pandey N, Lim WM. Research constituents, intellectual structure, and collaboration patterns in journal of international marketing: an analytical retrospective. J Int Mark. 2021;29:1–21.

    Article  Google Scholar 

  17. Zhang Y, Lim D, Yao Y, Dong C, Feng Z. Global research trends in radiotherapy for gliomas: a systematic bibliometric analysis. World Neurosurg. 2022;161:e355–62.

    Article  PubMed  Google Scholar 

  18. Das JP, Thulasidasan N, Ahmed I, Diamantopoulos A. Transarterial chemoembolization for hepatocellular carcinoma: a bibliometric analysis of the most cited articles. Jpn J Radiol. 2020;38:1190–6.

    Article  CAS  PubMed  Google Scholar 

  19. Van Eck NJ, Waltman L. Software survey: VOSviewer, a computer program for bibliometric mapping. Scientometrics. 2010;84:523–38.

    Article  PubMed  Google Scholar 

  20. Mulet-Forteza C, Genovart-Balaguer J, Merigo JM, Mauleon-Mendez E. Bibliometric structure of IJCHM in its 30 years. Int J Contemp Hosp Manag. 2019;31:4574–604.

    Article  Google Scholar 

  21. Gao Y, Shi SZ, Ma WJ, Chen J, Cai YT, Ge L, et al. Bibliometric analysis of global research on PD-1 and PD-L1 in the field of cancer. Int Immunopharmacol. 2019;72:374–84.

    Article  CAS  PubMed  Google Scholar 

  22. D’Arcangelo D, Giampietri C, Facchiano F, Facchiano A. BAMM: a preliminary bibliometric analysis on melanoma manuscripts. Pigment Cell Melanoma Res. 2013;26:415–7.

    Article  PubMed  Google Scholar 

  23. Huang TJ, Wu HY, Yang SD, Su B, Tang K, Quan ZX, et al. Global trends of researches on sacral fracture surgery a bibliometric study based on VOSviewer. Spine. 2020;45:E721–8.

    Article  PubMed  Google Scholar 

  24. Abe O, Abe R, Enomoto K, Kikuchi K, Koyama H, Masuda H, et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet. 2005;366:2087–106.

    Article  Google Scholar 

  25. Fisher B, Anderson S, Bryant J, Margolese RG, Deutsch M, Fisher ER, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med. 2002;347:1233–41.

    Article  PubMed  Google Scholar 

  26. Darby SC, Ewertz M, McGale P, Bennet AM, Blom-Goldman U, Bronnum D, et al. Risk of ischemic heart disease in women after radiotherapy for breast cancer. N Engl J Med. 2013;368:987–98.

    Article  CAS  PubMed  Google Scholar 

  27. McGale P, Taylor C, Correa C, Cutter D, Duane F, Ewertz M, et al. Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials. Lancet. 2014;383:2127–35.

    Article  CAS  PubMed  Google Scholar 

  28. Veronesi U, Cascinelli N, Mariani L, Greco M, Saccozzi R, Luini A, et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med. 2002;347:1227–32.

    Article  PubMed  Google Scholar 

  29. Whelan TJ, Pignol JP, Levine MN, Julian JA, MacKenzie R, Parpia S, et al. Long-term results of hypofractionated radiation therapy for breast cancer. N Engl J Med. 2010;362:513–20.

    Article  CAS  PubMed  Google Scholar 

  30. Overgaard M, Hansen PS, Overgaard J, Rose C, Andersson M, Bach F, et al. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial. N Engl J Med. 1997;337:949–55.

    Article  CAS  PubMed  Google Scholar 

  31. Bentzen SM, Agrawal RK, Aird EG, Barrett JM, Barrett-Lee PJ, Bentzen SM, et al. The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial. Lancet. 2008;371:1098–107.

    Article  CAS  PubMed  Google Scholar 

  32. Haviland JS, Owen JR, Dewar JA, Agrawal RK, Barrett J, Barrett-Lee PJ, et al. The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials. Lancet Oncol. 2013;14:1086–94.

    Article  PubMed  Google Scholar 

  33. Poortmans PM, Collette S, Kirkove C, Van Limbergen E, Budach V, Struikmans H, et al. Internal mammary and medial supraclavicular irradiation in breast cancer. N Engl J Med. 2015;373:317–27.

    Article  CAS  PubMed  Google Scholar 

  34. Mc WR. The principles of treatment by radiotherapy in breast carcinoma. Br J Cancer. 1950;4:368–71.

    Article  Google Scholar 

  35. Miglietta F, Griguolo G, Guarneri V, Dieci MV. Programmed cell death ligand 1 in breast cancer: technical aspects, prognostic implications, and predictive value. Oncologist. 2019;24:E1055–69.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. Ahn SK, Hwang JW. Global trends in immunotherapy research on breast cancer over the past 10 years. J Oncol. 2020;2020:4708394.

    Article  PubMed  PubMed Central  Google Scholar 

  37. Kodonas K, Fardi A, Gogos C, Economides N. Scientometric analysis of vital pulp therapy studies. Int Endod J. 2021;54:220–30.

    Article  CAS  PubMed  Google Scholar 

  38. DeSantis C, Siegel R, Bandi P, Jemal A. Breast cancer statistics, 2011. CA Cancer J Clin. 2011;61:409–18.

    Article  PubMed  Google Scholar 

  39. Anastasiadi Z, Lianos GD, Ignatiadou E, Harissis HV, Mitsis M. Breast cancer in young women: an overview. Updates Surg. 2017;69:313–7.

    Article  PubMed  Google Scholar 

  40. He MY, Rancoule C, Rehailia-Blanchard A, Espenel S, Trone JC, Bernichon E, et al. Radiotherapy in triple-negative breast cancer: current situation and upcoming strategies. Crit Rev Oncol Hematol. 2018;131:96–101.

    Article  PubMed  Google Scholar 

  41. Ning WJ, Liu X, Zeng HY, An ZQ, Luo WX, Xia NS. Recent progress in antibody-based therapeutics for triple-negative breast cancer. Expert Opin Drug Deliv. 2022;19:815–32.

    Article  CAS  PubMed  Google Scholar 

  42. Zhang R, Yang Y, Dong W, Lin M, He J, Zhang X, et al. D-mannose facilitates immunotherapy and radiotherapy of triple-negative breast cancer via degradation of PD-L1. Proc Natl Acad Sci USA. 2022. https://doi.org/10.1073/pnas.2114851119.

    Article  PubMed  PubMed Central  Google Scholar 

  43. Bennion NR, Baine M, Granatowicz A, Wahl AO. Accelerated partial breast radiotherapy: a review of the literature and future directions. Gland Surg. 2018;7:596–610.

    Article  PubMed  PubMed Central  Google Scholar 

  44. Orecchia R, Veronesi U, Maisonneuve P, Galimberti VE, Lazzari R, Veronesi P, et al. Intraoperative irradiation for early breast cancer (ELIOT): long-term recurrence and survival outcomes from a single-centre, randomised, phase 3 equivalence trial. Lancet Oncol. 2021;22:597–608.

    Article  PubMed  Google Scholar 

  45. Grossberg AJ, Lei X, Xu T, Shaitelman SF, Hoffman KE, Bloom ES, et al. Association of transforming growth factor beta polymorphism C-509T with radiation-induced fibrosis among patients with early-stage breast cancer: a secondary analysis of a randomized clinical trial. JAMA Oncol. 2018;4:1751–7.

    Article  PubMed  PubMed Central  Google Scholar 

  46. Woo J, Moon BI, Kwon H, Lim W. Effect of radiotherapy sequence on long-term outcome in patients with node-positive breast cancer: a retrospective study. Sci Rep. 2022;12:10729.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  47. Cao L, Xu C, Cai G, Qi WX, Cai R, Wang SB, et al. How does the interval between completion of adjuvant chemotherapy and initiation of radiotherapy impact clinical outcomes in operable breast cancer patients? Ann Surg Oncol. 2021;28:2155–68.

    Article  PubMed  Google Scholar 

  48. Woodward SG, Varshney K, Anne PR, George BJ, Willis AI. Trends in use of hypofractionated whole breast radiation in breast cancer: an analysis of the national cancer database. Int J Radiat Oncol Biol Phys. 2021;109:449–57.

    Article  PubMed  Google Scholar 

  49. Smith BD, Bellon JR, Blitzblau R, Freedman G, Haffty B, Hahn C, et al. Radiation therapy for the whole breast: Executive summary of an American Society for Radiation Oncology (ASTRO) evidence-based guideline. Pract Radiat Oncol. 2018;8:145–52.

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

This study was funded by grants from National Natural Science Foundation of China, China (No. 82173460).

Author information

Authors and Affiliations

Authors

Contributions

Conceptualization, methodology, formal analysis and investigation, writing—original draft preparation, writing—review and editing: BJ; conceptualization, methodology, writing—original draft preparation, writing—review and editing: DL; conceptualization, methodology, formal analysis and investigation, writing—original draft preparation: YZ; conceptualization, methodology, formal analysis and investigation, writing—original draft preparation: CD; conceptualization, methodology, writing—original draft preparation, writing—review and editing, funding acquisition, resources, supervision: ZF.

Corresponding author

Correspondence to Zhihui Feng.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical statement

This article does not contain any studies with human participants or animals performed by any of the authors. The data used in this research is freely available in the public domains (e.g., published biographies) and ethics approval was obtained at the time of the original data collection.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Jia, B., Lim, D., Zhang, Y. et al. Global research trends in radiotherapy for breast cancer: a systematic bibliometric analysis. Jpn J Radiol 41, 648–659 (2023). https://doi.org/10.1007/s11604-022-01383-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11604-022-01383-x

Keywords

Navigation